FMA
EDIT icon

FNY Managed Accounts’s Editas Medicine EDIT Stock Holding History

FNY Managed Accounts’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$2K Buy
+77
New +$2.74K ﹤0.01% 376

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FNY Managed Accounts's EDIT Position: Q1 2018 in Review

FNY Managed Accounts opened a new position in Editas Medicine (EDIT) in Q1 2018: 77 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #376 among its holdings.

197 funds tracked by Wall St. Rank hold EDIT as of Q1 2018.

  • FNY Managed Accounts held 77 shares of Editas Medicine worth $2K as of Q1 2018.
  • Editas Medicine was a new FNY Managed Accounts position in Q1 2018.
  • Editas Medicine made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #376 holding.
  • 197 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.